Subtitle
Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With PT for Brain and Skull Base Tumors.
Subtitle
Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With PT for Brain and Skull Base Tumors.
Proto therapy Time
March 2018
Executive summary
To examine the rate of and identify risk factors for vasculopathy after proton therapy in pediatric patients with central nervous system and skull base tumors, the Jacksonville group analyzed 644 pediatric patients with central nervous system and skull base tumors were treated with proton therapy in their center.
Top cancer treatments
Related contents
Proton Therapy Publication
September 2024
Proton therapy for adult-type diffuse glioma: A systematic review.
Proton Therapy Publication
October 2024
Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas.
Proton Therapy Publication
October 2024
Patient reported fatigue after proton therapy for malignant brain tumours - Is there a relation between radiation dose and brain structures?
Proton Therapy Publication
September 2024
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma.
Proton Therapy Publication
May 2024
Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
Proton Therapy Publication
May 2024
Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.
Proton Therapy Publication
June 2024
Possible association of dose rate and the development of late visual toxicity for patients with intracranial tumours treated with pencil beam scanned proton therapy.
Proton Therapy Publication
August 2024
Proton therapy for intracranial meningioma: a single-institution retrospective analysis of efficacy, survival and toxicity outcomes.
Proton Therapy Publication
August 2024
Controversies in neuro-oncology: Focal proton versus photon radiation therapy for adult brain tumors.